Results 161 to 170 of about 1,855,208 (237)

Randomised trial of the P2X₃ receptor antagonist sivopixant for refractory chronic cough. [PDF]

Eur Respir J, 2022
Niimi A, Saito J, Kamei T, Shinkai M, Ishihara H, Machida M, Miyazaki S.   +6 more
europepmc   +1 more source

Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia (Letter)

To the Editor: The recent publication in this Journal of the position statement summary on cough in children and adults is welcome and timely.1 Much has changed in the understanding of chronic cough since the last Australian guideline was published in ...
Birring, S, Turner, R
core   +1 more source

Camlipixant: A New Hope for Refractory Chronic Cough? [PDF]

Am J Respir Crit Care Med
Satia I, Mazzone SB.
europepmc   +1 more source

Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough? [PDF]

ERJ Open Res, 2021
Sundar KM, Stark AC, Hu N, Barkmeier-Kraemer J.   +3 more
europepmc   +1 more source

The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial. [PDF]

BMC Med
Wang S, Wu H, Zhou Y, Li W, Zhang T, Shi C, Yu L, Xu X.   +7 more
europepmc   +1 more source

Subcutaneous octreotide as a therapeutic option for refractory chronic cough: subjective response pattern and adverse effects from a retrospective single-centre case series. [PDF]

ERJ Open Res, 2023
Brindle K, Zhang M, Carter N, Morice AH.
europepmc   +1 more source

Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study. [PDF]

Ther Adv Respir Dis, 2023
Zhang M, Morice AH, Si F, Zhang L, Chen Q, Wang S, Zhu Y, Xu X, Yu L, Qiu Z.   +9 more
europepmc   +1 more source

Efficacy of morphine on cough in patients with repeat expansions of <i>RFC1</i> and refractory chronic cough. [PDF]

ERJ Open Res
Guilleminault L, Chazelas P, Magdelaine C, Villeneuve T, Lia AS, Magy L.   +5 more
europepmc   +1 more source

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin. [PDF]

Eur Respir J
Whetstone C, Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L, Howie K, Killian K, Holt K, Sehmi R, Smith JA, O'Byrne PM, Satia I, Gauvreau GM.   +17 more
europepmc   +1 more source

P2X3-selective mechanism of Gefapixant, a drug candidate for the treatment of refractory chronic cough. [PDF]

Comput Struct Biotechnol J, 2022
Cui WW, Wang SY, Zhang YQ, Wang Y, Fan YZ, Guo CR, Li XH, Lei YT, Wang WH, Yang XN, Hattori M, Li CZ, Wang J, Yu Y.   +13 more
europepmc   +1 more source